α2δ-1 coexpression or nerve injury does not reduce the protein levels of GluA1 and GluA2 (12, 13), so this α2δ-1–induced AMPAR degradation appears to be GluA3 subtype specific. The gene discussed is GRIA3; the disease is injury.